EUCTR2005-004008-36-IT进行中（未招募）不适用
Efficacy and safety of treatment with Anakinra in patients with CINCA/MUCKLE-WELLS syndrome and systemic juvenile idiopathic arthritis
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patients with CINCA/MUCKLE-WELLS:Patients with CINCA/MUCKLE-WELLS with active disease Patients with systemic juvenile idiopathic arthritis: Patients with systemic juvenile idiopathic arthritis with active disease
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 0
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Treatment with anti-TNF therapy Infections on-going Immunosupressive treatment in six previous weeks
研究者
相似试验
进行中（未招募）
1 期
Safety and efficacy of anakinra treatment for patients with persistent respiratory symptoms post acute covid and immune system activation: the PRECISION double-blind, randomized clinical trialCTIS2023-508123-12-00Hellenic Institute For The Study Of Sepsis182
尚未招募
3 期
effect of anakinra in treatment of COVID-19IRCT20120703010178N20Persisgen Par Pharmaceutical Company30
进行中（未招募）
1 期
Efficacy and safety of anakinra (antagonist of the interleukin-1 receptor) in the treatment of periarticular inflammation in patients refractory to NSAID and / or steroidsInflammation in periarticular structures in patients refractory to NSAIDs and / or corticosteroids.EUCTR2013-005402-65-ESInstitut de Recerca HSCSP20
已完成
2 期
Clinical evaluation of the effect of a classical siddha drug akkara ennai for the treatment of Oral UlcerCTRI/2019/06/019921A Arumuga kani55
尚未招募
2 期
Treatment of Diabetic Peripheral Neuropathy through ayurvedic line of management.CTRI/2023/10/058822Dr H S Harshitha